| __timestamp | Intra-Cellular Therapies, Inc. | Rhythm Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 10337679 | 1213000 |
| Thursday, January 1, 2015 | 18187286 | 3425000 |
| Friday, January 1, 2016 | 24758063 | 6311000 |
| Sunday, January 1, 2017 | 23666957 | 9518000 |
| Monday, January 1, 2018 | 30099855 | 28080000 |
| Tuesday, January 1, 2019 | 64947625 | 36550000 |
| Wednesday, January 1, 2020 | 186363444 | 46125000 |
| Friday, January 1, 2021 | 272611040 | 68486000 |
| Saturday, January 1, 2022 | 358782000 | 92032000 |
| Sunday, January 1, 2023 | 409864000 | 117532000 |
Unlocking the unknown
In the competitive world of biopharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Over the past decade, Intra-Cellular Therapies, Inc. and Rhythm Pharmaceuticals, Inc. have shown distinct trajectories in their SG&A spending. From 2014 to 2023, Intra-Cellular Therapies saw a staggering increase of nearly 3,900% in SG&A expenses, reflecting their aggressive growth and expansion strategies. In contrast, Rhythm Pharmaceuticals experienced a more moderate rise of approximately 9,600%, indicating a steady scaling of operations.
By 2023, Intra-Cellular Therapies' SG&A expenses were nearly 3.5 times higher than Rhythm Pharmaceuticals, highlighting their larger operational scale. This analysis provides a window into how these companies allocate resources to support their growth ambitions, offering valuable insights for investors and industry analysts alike.
Cost Management Insights: SG&A Expenses for Sanofi and Rhythm Pharmaceuticals, Inc.
Comparing SG&A Expenses: Zoetis Inc. vs Rhythm Pharmaceuticals, Inc. Trends and Insights
Breaking Down SG&A Expenses: argenx SE vs Intra-Cellular Therapies, Inc.
Comparing SG&A Expenses: Intra-Cellular Therapies, Inc. vs Merus N.V. Trends and Insights
Who Optimizes SG&A Costs Better? Intra-Cellular Therapies, Inc. or Soleno Therapeutics, Inc.
Intra-Cellular Therapies, Inc. or Evotec SE: Who Manages SG&A Costs Better?
Intra-Cellular Therapies, Inc. vs Xencor, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Corcept Therapeutics Incorporated and Rhythm Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Rhythm Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Rhythm Pharmaceuticals, Inc. or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Rhythm Pharmaceuticals, Inc. vs Dynavax Technologies Corporation
Breaking Down SG&A Expenses: Rhythm Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.